[ Price : $8.95]
FDA accepts for review a supplemental BLA for Gazyva (obinutuzumab) for treating lupus nephritis.[ Price : $8.95]
An Ohio State University business school study finds that generic drugs made in India are 54% more likely to be associated with se...[ Price : $8.95]
FDA places a clinical hold on BioNTechs Phase 1/2a dose escalation clinical trial evaluating an investigational RNA-based vaccine ...[ Price : $8.95]
FDA approves an ARS Pharmaceuticals supplemental NDA for Neffy (epinephrine nasal spray 1mg) for treating Type I allergic reaction...[ Price : $8.95]
FDA warns Indias Granules India Limited about CGMP violations in its production of finished drugs.[ Price : $8.95]
Two stakeholders suggest changes to an FDA draft guidance on protocol deviations in clinical studies.[ Price : $8.95]
The ethics form submitted to HHS by FDA commissioner nominee Martin Makary says he will resign his position at Johns Hopkins Unive...[ Price : $8.95]
FDA warns Pleasantville, IA-based Chem-Tech about CGMP violations in its manufacturing of finished drugs.